Over-expression of the functional interleukin-11α receptor in the development of B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 42, Issue 1-2, 2001, Pages 195-205

  Tsimanis, A ^a   Shvidel, L ^a   Klepfish, A ^a   Shtalrid, M ^a   Kalinkovich, A ^a   Berrebi, A ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

B chronic lymphocytic leukemia; Expression; Interleukin 11; Interleukin 11 receptor

Indexed keywords

CYTOKINE; DEXAMETHASONE; INTERLEUKIN 11; INTERLEUKIN RECEPTOR; RECOMBINANT INTERLEUKIN 11;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CANCER CELL CULTURE; CELL ACTIVATION; CELL COUNT; CELL DEATH; CELL SIZE; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DRUG RESISTANCE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034920163     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097691     Document Type: Article

References (44)

1. Chronic lymphocytic leukemia
2. Advances in the biology and treatment of B-cell chronic leukemia
3. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukemia cells following their culture in vitro
4. Autocrine and paracrine growth loops in chronic lymphocytic leukemia
5. Cytokine gene expression in B-cell chronic lymphocytic leukeamia: Evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
6. Expression of interleukin-1α, interleukin-1β and interleukin-6 in chronic lymphocytic leukemia (B-CLL) cells from a patients at different stages of disease progression
7. Interleukin-6 inhibits the proliferation of chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-α or -β
8. Interleukin-6 gene expression in normal and neoplastic B-cells
9. Production of tumor necrosis factor-α by B-cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease
10. Tumour necrosis factor production in B-cell chronic lymphocytic leukemia
11. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia
12. Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukemia inversely correlates with progression of disease
13. The role of interleukin-10 in chronic lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death
14. Interleukin-10 induces apoptotic cell death of B-chronic lymphocytic leukemia
15. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β
16. Expression and functional role of tumour necrosis factor receptors on leukaemic cells from patients with type B chronic lymphocytic leukemia
17. The granulocyte colony-stimulating factor (G-CSF)/G-CSF receptor (G-CSFR) system in B-cell chronic lymphocytic leukemia
18. Identification of B-cell growth factors (Interleukin-14; High molecular weight B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas
19. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells
20. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
21. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia
22. Interleukin-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression
23. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro
24. Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine
25. Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenvironment
26. Interleukin-11 acts as autocrine growth factor for human megakaryoblastic cell lines
27. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Rα) display normal hematopiesis
28. Cytokines at the research - Clinical interface: Potential applications
29. The efficacy of IL-3, SCF, IL-6 and IL-11 in treating thrombocytopenia
30. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis
31. Interleukin-11: A new cytokine critical for osteoclast development
32. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation
33. Interleukin-11 promotes accesory cell-dependent B-cell differentiation in humans
34. The human IL-11 receptor requires gp130 for signalling: Demonstration by molecular cloning of the receptor
35. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11
36. B-cell chronic lymphocytic leukemia: Present status and future directions
37. cDNA synthesis and cloning
38. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
39. Diminished production of interleukin-6 in chronic lymphocytic leukemia (B-CLL) cells from patients at advanced stages of disease
40. Growth factors can protect B-chronic lymphocytic leukemia cell against programmed cell death without stimulating proliferation
41. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell line
42. Role of transforming growth factor-β in chronic lymphocytic leukemia
43. Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukemia: Correlation with the expression of TGF-β receptors
44. Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways